Embodiments of the present invention generally relate to a breathing system designed to provide gas, such as an oxygen and medicine mixture, to a patient.
Hospitalized patients with pulmonary or cardiovascular health issues often require supplemental oxygen. Typically, supplemental oxygen is delivered to a patient from an oxygen source that is interconnected by tubing to a patient interface, e.g., a mouth piece or a mask. In addition, some patients require medicine, which is delivered to the patient in the form of aerosolized particles mixed with the oxygen by a nebulizer that is interconnected to the tubing and positioned between the oxygen source and the patient interface. “Gas” as used herein shall refer to the mixture of oxygen and medicine. Those of skill in the art will appreciate that the source may deliver compressed air, a mixture of helium and oxygen, or any other substance that is typically used for patient care.
One drawback of prior art breathing systems is that the patient often re-breathes exhaled gas which reduces the amount of medicine-rich gas that would otherwise be received or drawn in by the patient. To avoid this drawback, breathing systems often include an inlet check valve or similar device that prevents exhaled air from intermingling with the incoming or supplied gas. More specifically, the pressure of the exhaled gas is sufficient to close the inlet check valve so that exhaled gas is forced through vents or an outlet port located between the patient and the inlet check valve. Pressure generated by the patient's inhalation opens the inlet check valve which allows the patient to breath in the prescribed gas.
It is another drawback that breathing systems of the prior art often waste medicine. More specifically, the source of many breathing systems continuously output oxygen at a predetermined but variable mass flow rate and pressure. Thus, when the patient is not inhaling, i.e., during exhalation or during the dwell period characterized as the time between inhalation and exhalation, gas continues to be delivered. As a result, the oversupplied gas is vented through the outlet port and/or through mask vents. To account for this decrease in medicine delivery to the patient, health care providers typically increase the amount of medicine added to the incoming oxygen. In an extreme example, a healthcare provider will prescribe three times the required dosage to accommodate losses, which is wasteful and increases healthcare costs. One attempt to solve the problem of waste has been to incorporate a reservoir bag into the gas delivery system to capture the delivered gas when the patient is not inhaling and subsequently deliver the captured gas to the patient upon the next breadth, which reduces the amount of gas vented to atmosphere. When the patient does inhale, the gas stored in the reservoir bag is inhaled along with gas that is being continuously delivered by the supply source.
Often reservoir bags are thick-walled and made of a durable material to withstand damage associated with shipping, handling, and use. Thick-walled construction, however, affects the ability of the bag to inflate and therefore adversely affects the ability of the bag to capture excess gas. It follows that as the pressure required to inflate a thick-walled reservoir is greater than the pressure required to open the inlet check valve, the pressurized gas delivered to the patient during the dwell time will often flow to the mask only to be vented. Stated differently, the inlet check valve of many breathing systems may open without the reservoir bag being filled and the gas will vent to atmosphere through the outlet port or mask vents rather than filling the reservoir.
One ineffective response to this problem is to increase the pressure of the oxygen source, and thus the gas, to ensure the bag inflates. However, increasing the source pressure will amplify the wasteful effect if the reservoir bag does not inflate quickly. That is, the pressure of the system is directly proportional to the gas mass flow rate which in turn is directly proportional to gas losses through the outlet port when the inlet check valve inevitably opens. And, even if the higher pressure gas completely inflates the reservoir bag, eventually the pressure of the incoming gas will urge the inlet check valve open, which allows the gas to vent through the outlet port. As one of skill in the art will appreciate, losses will be greater than those experienced by a system operating at a lower pressure.
Another way to address the medicine waste issue is to vary the size of the opening of the outlet port. U.S. Pat. No. 5,613,489 (“the '489 patent”), which is incorporated herein by reference, is directed to an outlet port comprised of a selectively adjustable orifice that provides adjustable resistance to exhalation. As one of skill in the art will appreciate, the greater the resistance to exhalation, the greater the pressure within the housing, which keeps the inlet check valve closed when the patient exhales and during the dwell time. The adjustable orifice may also be used to control exhalation by producing a positive expiratory pressure (PEP) which enhances patient therapy. The orifice of the exhalation port described in the '489 is adjusted by altering a wedge-shaped opening from about 10 degrees to about 60 degrees. One drawback with this method of controlling exhalation is that a path is always open. Thus, if the system of the '489 patent is used with a self-inflating reservoir, as will be described in detail below, ambient air will be drawn in through the orifice when the patient inhales. That is, patients with poor lung function will not be able to provide enough negative pressure during inhalation to collapse a self-inflating reservoir, which maximizes medicine delivery, without the orifice leaking ambient air.
Accordingly, there is a long standing and unresolved need to provide a system for delivering medicine to a patient that efficiently stores a reserve of gas when the patient is not inhaling, thereby eliminating or substantially reducing medicine waste by making the reserve available to the patient when he or she subsequently inhales.
Embodiments of the present invention provide a gas delivery system with a reservoir wherein internal system pressure requirements are established that ensure that continuously produced and supplied gas is captured by filling or substantially filling a reservoir when the patient is not inhaling. More specifically, one embodiment of the present invention employs an inlet check valve with increased resistance. Further, resistance to opening the inlet check valve may be added to the system, such as by placing a filter, a throttle—which may or may not be variable, decreased diameter tubing, or some other medically inert porous obstruction upstream of an outlet port, which is located between the patient and the inlet check valve. As used herein, “upstream” refers to a position closer to the gas supply and away from the patient. Still further, the wall thickness of the inflatable reservoir may be reduced, which will facilitate inflation by reducing the pressure needed to inflate the reservoir. Each of these solutions, alone or in combination, will capture the continuously-produced and supplied gas such that a reserve is available for the patient, which will reduce waste. The resistance to gas flow occurs before the gas reaches the outlet port of the delivery system. In other words, any structure or component added, altered, or selectively altered for purposes of increasing the internal resistance to gas flow toward the outlet port must not be positioned between a patient interface, i.e., a mouth piece or mask, and the outlet port, otherwise the solution will be ineffective as the gas will vent to atmosphere through the outlet port. Additionally, the internal system pressure may be adjustable relative to the volume and rate of the patient's breath cycle such that the internal system pressure may be set to cause the reservoir to fill or is substantially fill before each inhalation cycle.
It is another aspect of some embodiments of the present invention to provide self-inflating reservoir. More specifically, reservoirs made of a resilient material, such as a shape-memory polymer, are employed that return to their original shape after compression caused by inhalation. The material used by one embodiment is flexible polyvinyl chloride (PVC) or other similar elastomeric materials, such as silicon or styrenic block copolymer (SBC) manufactured by Kraton Performance Polymers Inc. Further, as previously noted, the wall thickness of the contemplated reservoir may be directly proportional to the pressure required to inflate the reservoir. Effective wall thickness is a function of the material selected and may range from about 0.100 mm near the opening of the reservoir to about 0.030 mm in some areas of the primary gas-holding portion. In one embodiment, the wall thickness is consistent from the opening to about the midway point of a spherical reservoir (a first hemi-spherical portion) wherein the remainder of the spherical reservoir from the midway point to the end of the reservoir (the opposed hemispherical portion) is made of a thinner or different material. By defining the reservoir material of manufacture and/or wall thickness, the amount of negative pressure created by the reservoir as it rebounds can be predetermined. Furthermore, the negative pressure assists in filling the reservoir and assists in keeping the inlet check valve closed during patient exhalation and dwell time.
It is also noted that patients frequently do not breathe as deeply as they should following many medical procedures. To resolve this, doctors will prescribe the use of incentive spirometer which gives the patient and doctor a visual indication that they are breathing deeply. The shape-memory reservoir of some embodiments of the invention will also provide such visual feedback to the patient and the patient's doctor or attendant. More specifically, it is yet another aspect of the present invention to provide a somewhat stiff but resilient reservoir that will resist inhalation, which is a helpful therapy tool. More specifically, inhalation of gas from a reservoir of a contemplated embodiment of the present invention will take more patient effort. Increased effort translates into a deeper breath that will force medication deeper into the patient's lungs. Forcing the patient to breathe deeper has the added benefit of preventing pneumonia as deep breaths necessarily help prevent fluid build-up in the patient's lungs. Further, by monitoring the degree of inhalation by the patient through observation of the shape of the reservoir during patient inhalation and exhalation (e.g., the reservoir expanding on exhalation and collapsing or contracting to a degree during inhalation), the drug administration process may be similarly monitored, and as such the reservoir provides biofeedback to the patient and/or the patient's attendant regarding the patient's breathing pattern.
It is another aspect of the present invention to provide a reservoir that collapses in a controlled fashion to ensure that the gas contained in the reservoir is completely expelled. Bag reservoirs of the prior art can collapse in such a way to block the reservoir opening and thereby trap some gas inside the reservoir. Thus, reservoirs of some embodiments of the present invention employ thicker and stiffer walls adjacent to the open end than the gas-holding portion of the reservoir to prevent the collapsing reservoir from blocking the open end and trapping gas. Other reservoirs employ stiffening ribs or seams that help control reservoir collapse to prevent blocking the opening. Still other reservoirs of the contemplated invention are made of a combination of materials that collapse in a predetermined manner. For example, in one embodiment the reservoir is made of two distinct materials, one stiff and less apt to collapse than the other. In operation, the more flexible material, which is located away from the reservoir opening, will collapse first. Any of these reservoir configurations and those similar thereto has the advantage of maintaining the opening while having the primary gas-holding portion fully collapse upon inhalation, which allows substantially all of the stored gas to be inhaled. Alternatively, the reservoir opening may be held open with an adapter that is inserted into the opening.
It is a related aspect of the present invention that condensation, which contains medicine, in the reservoir is reduced. More specifically, collapsed walls of prior art reservoir bags may stick together and trap gas within folds, creases, or pockets which leaves medication adhered to the inside surface of the bag. A test of one embodiment of the present invention reduced the amount of condensation in the reservoir by 90%.
It is yet another aspect of the present invention to provide a breathing system, comprising: a gas source; a housing having: a first inlet in fluid communication with said gas source, a first port in fluid communication with a patient interface, and a second port in fluid communication with a reservoir; an outlet, wherein said housing includes a first check valve positioned between said first inlet and said outlet; and wherein output from said gas source flows to said first inlet and to said reservoir, the output inflating said reservoir until said first check valve is opened, which allows the output to be directed from said reservoir and said gas source to said patient interface.
It is another aspect of the present invention to provide a method of reducing waste in the delivery of aerosolized medicine or gas to a patient comprising: providing a gas source; providing a housing having: a first port associated with said gas source, a second port associated with a reservoir, a third port associated with a patient interface, and a fourth port, and a check valve positioned between said first port and said fourth port; delivering a gas from said gas source to said first port of said housing; directing said gas to said reservoir via said second port; opening said check valve upon patient inhalation; directing said gas from said reservoir to said patient interface; closing said check valve when the patient is not inhaling; and directing exhaled air out of said housing through said fourth port.
While the following disclosure describes the invention in connection with those embodiments presented, one should understand that the invention is not strictly limited to these embodiments. Furthermore, one should understand that the drawings are not necessarily to scale and that in certain instances, the disclosure may not include details that are not necessary for an understanding of the present invention, such as conventional details of fabrication and assembly.
Turning to
The flow rate at which oxygen is supplied to the nebulizer is a known amount and may be adjusted as required. In one embodiment, the pressure being delivered by the source is greater than the pressure required to open the inlet check valve 50, but the flow rate of the pressurized oxygen is decreased so that it takes some time for the pressure in the reservoir 44 and housing 32 to reach a level that would open the inlet check valve 50. Accordingly, when a patient is not inhaling, the gas exiting nebulizer 38 will accumulate in the reservoir. At some point, however, the inlet check valve 50 will open due to the pressure build up in the housing 32 and the reservoir 44, if the valve is not otherwise opened by the patient's inhalation. Upon inhalation, the valve will open or remain open and allow the patient to receive the gas from the nebulizer 38, as well as the supply of gas contained in the reservoir 44. If the patient is not inhaling at this time, the excess gas will vent through port 52 and PEP valve 53.
The flow rate of the gas from the nebulizer 38 should be adjusted to correspond with the patient's inhalation such that the volume of gas that accumulates in the reservoir matches or nearly matches the patient's inhalation volume intake, accounting for the volume of gas that would also be simultaneously supplied from the nebulizer. Should the patient over-breathe and deplete the volume of gas in the reservoir, the patient may still inhale the gas being generated by the nebulizer as well as ambient air drawn through an outlet 52 or Positive Expiratory Pressure (PEP) valve 53. When the patient exhales the inlet check valve 50 will close and all exhaled gas will exit through the outlet 52 or the PEP valve 53. One of skill in the art will appreciate that the exhaled gas also may exit though another outlet integrated into the housing 32, the mouth piece 34, the mask (if applicable), etc. That is, the PEP valve 53 is not necessarily required for the contemplated invention to function. The PEP valve 53 may employ a member 56 that is selectively adjusted to control the flow of fluid therethrough. In one embodiment the PEP valve 53 is used in conjunction with a filter mechanism 54 to filter exhaled gases, remove contaminants, bacteria, viruses and other contaminates for the safety of healthcare workers and others attending to the needs of the patient. During exhalation and any pause before the next inhalation, the gas will inflate the reservoir 44.
To ensure gas is not wasted when the patient is not inhaling and to ensure the reservoir 44 fills, even in the case of patients requiring high oxygen flow rates, which generate higher internal pressures that could cause the inlet check valve 50 to open at times other then when the patient is inhaling, the resistance of the inlet check valve 50 may be increased. In one embodiment, a manually adjustable spring is used to alter the resistance of the valve 50. Alternatively, a second check valve of increased resistance (not shown) may be placed in the delivery system upstream between the PEP valve 53 and inlet check valve 50. This second valve would compensate for situations where the inlet check valve 50 would otherwise open at times other than during patient inhalation. Further, and by way of example, resistance could take the form of one or more filters, some type of inert or non-harmful but porous obstruction, a throttle in the tubing, a throttle in the housing 32, a circuitous air path, a flow path comprising flexible walls that expand and contract with pressure changes, tubing with integrated pressure relief characteristics (i.e., a hole covered by a flexible member that allows gas to escape when the pressure of the gas reaches a predetermined level), or a combination of one or more of these options. An important feature is that the internal resistance to gas flow toward the mouth piece upstream of the PEP valve 53 is greater than that required to fill the reservoir bag 44.
Referring now to
When the oxygen source is turned on, pressurized oxygen will fill the reservoir bag 68 until the patient inhales. On inhalation, the valve 66 opens and valve(s) 62 close causing all of the inhaled gases to come from the oxygen supply 74 and/or the reservoir 68. The flow of oxygen may be adjusted to meet the patient's requirements. On exhalation, valve 66 closes and valve(s) 62 open to allow the exhaled gas to escape from the mask and the reservoir bag 68 to refill with oxygen. A nebulizer (not shown) may be added between the housing 64 and the oxygen supply line 72 and the system will work in the same way but the reservoir and patient will be provided with an aerosolized mixture of oxygen and medicine or ambient air and medicine.
With the current state of the art non-re-breather mask systems, the reservoir bag is stiff, as described above, and in order to fill the reservoir bag when the patient is not inhaling the pressure from the oxygen supply must be sufficiently large. However, the increased pressure also causes outlet valves 62 and 66 to open causing at least some of the oxygen or aerosol mixture to exit out to atmosphere when the patient is not inhaling. Oxygen or aerosol mixture is thus wasted and the quantity of medicine or oxygen must be increased to accommodate the loss and to ensure the patient receives the prescribed amount of medicine.
In one embodiment of the present invention the pressure required to open valve 66 is adjusted to require a pressure greater than the pressure required to substantially fill the reservoir 68 but is less than the pressure needed to open the valve 66 when the patient inhales. This assures the patient receives the prescribed oxygen level, requires less oxygen flow to achieve the prescribed oxygen levels and reduces or eliminates the loss of oxygen or the aerosol mixture. The system of
Some embodiments of the present invention employ a semi-rigid, i.e., flexible reservoir. For example, the reservoir may be comprised at least partially of a material that reacts to a negative pressure associated with inhalation but maintains a predetermined shape when not exposed to a pressure variation. This “memory-shape” or “self-inflating” reservoir will thus return to its static or original shape in the absence of external or internal pressure, similar to the bulb of an eyedropper, an aspirator, etc. The material of manufacture of the contemplated reservoir is any number of shape-memory or flexible plastics, for example, flexible PVC of a relatively thin wall thickness in the range of 0.005-0.015 mm. As one of skill in the art will appreciate the contemplated wall thickness would require adjustment depending on the material used. That is, the thicker the material the more memory the part would possess but the less likely it would collapse during inhalation. In addition, if the wall thickness is too thin it would not have enough rigidity to be self inflating. One of skill in the art will appreciate that the reservoir can be substantially rigid but includes a flexible portion that allows expansion or contraction of the flexible portion in response to patient breathing.
The contemplated reservoir would facilitate cleaning or sanitation thereof as it will substantially maintain its shape when disconnected from the system as the opening associated therewith may be oriented to allow drainage of cleaning fluid. This aspect has an advantage over a substantially collapsible, less rigid bag that would prevent the escape of moisture, thereby promoting bacteria and or mold growth which reduces the life expectancy thereof.
The housing of this embodiment of the present invention also includes outlet PEP valve 53 associated with the outlet 52 similar to that shown and described in U.S. Pat. No. 5,613,489, which employs an orifice 97 that may be selectively adjusted by rotating a member 56 to control the amount of exhaled air exiting the orifice 97. More specifically, by reducing the size of the orifice 97, the patient will have to exhale more vigorously to accomplish a full and complete exhalation cycle. The orifice 97 of this embodiment is associated with an outlet check valve 98 that does not allow ambient air to “leak” into the system when the patient inhales and adds little or no resistance to exhalation. Other embodiments of the present invention omit the valve 94 and only employ the outlet check valve 98. The outlet check valve 98 may be a diaphragm or butterfly valve that is associated with a valve retainer 99 interconnected to the outlet 52. Further, the valve 98 can be used in conjunction with an existing variable resistor, if needed.
Referring now particularly to
A typical inhalation/exhalation cycle is shown in
A test of one embodiment of the present invention was performed using a nebulizer and a self-inflating, shape memory, reservoir. A respiratory pump was used to represent the inhalation and exhalation of a patient that was able to provide 500 ml per breath, and inhalation to exhalation ration of 1:1 at fifteen breaths per minute. A high efficiency particulate air (HEPA) filter, which represented the patient, was placed between the respiratory pump and the nebulizer. The HEPA filter, nebulizer, and the body of the self inflating reservoir were weighed prior to testing. Further, 3 ccs of sterile saline were placed in a bowl of the nebulizer and a nebulizer was weighed again. To commence the test, the respiratory pump was switched on and the flow of nebulizer was set to about 8 liters per minute. The system was allowed to function until the nebulizer sputtered, which indicated that nearly all of the sterile saline (representing medicine) was completely administered. All the components were then weighed and the amount of weight loss of the nebulizer was compared to the weight gain of the other parts of the system. The self-inflating reservoir of some embodiments of the present invention gained less than 1% of weight, which is attributed to the nebulized solution, i.e., trapped medicine. For comparison, the systems of the prior art that use a reservoir bag were tested. Such systems yielded residual condensation in the bag (trapped medicine) greater than 10% of the total fluid nebulized. By reducing the amount of condensation occurring inside the reservoir, costs are reduced and the amount of medicine reaching the patient is idealized.
The present invention, in various embodiments, includes components, methods, processes, systems and/or apparatus substantially as depicted and described herein, including various embodiments, sub combinations, and subsets thereof. Those of skill in the art will understand how to make and use the present invention after understanding the present disclosure. The present invention, in various embodiments, includes providing devices and processes in the absence of items not depicted and/or described herein or in various embodiments hereof, including in the absence of such items as may have been used in previous devices or processes, e.g., for improving performance, achieving ease and or reducing cost of implementation.
The foregoing discussion of the invention has been presented for purposes of illustration and description. The foregoing is not intended to limit the invention to the form or forms disclosed herein. In the foregoing Detailed Description for example, various features of the invention are grouped together in one or more embodiments for the purpose of streamlining the disclosure. The features of the embodiments of the invention may be combined in alternate embodiments other than those discussed above. This method of disclosure is not to be interpreted as reflecting an intention that the claimed invention requires more features than are expressly recited in each claim. Rather, as the following claims reflect, inventive aspects lie in less than all features of a single foregoing disclosed embodiment. Thus, the following claims are hereby incorporated into this Detailed Description, with each claim standing on its own as a separate preferred embodiment of the invention.
Moreover, though the description of the invention has included description of one or more embodiments and certain variations and modifications, other variations, combinations, and modifications are within the scope of the invention, e.g., as may be within the skill and knowledge of those in the art, after understanding the present disclosure. It is intended to obtain rights which include alternative embodiments to the extent permitted, including alternate, interchangeable and/or equivalent structures, functions, ranges or steps to those claimed, whether or not such alternate, interchangeable and/or equivalent structures, functions, ranges or steps are disclosed herein, and without intending to publicly dedicate any patentable subject matter.
This application is a Continuation-In-Part of U.S. patent Ser. No. 12/688,295, filed Jan. 15, 2010, which claims the benefit of U.S. Provisional Application Ser. No. 61/145,318, filed Jan. 16, 2009, the entirety of both applications being incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
3906996 | DePass et al. | Sep 1975 | A |
3967619 | Story et al. | Jul 1976 | A |
4088131 | Elam et al. | May 1978 | A |
4192301 | Hardwick | Mar 1980 | A |
4676239 | Humphrey | Jun 1987 | A |
4823784 | Bordoni et al. | Apr 1989 | A |
5020530 | Miller | Jun 1991 | A |
5061241 | Stephens, Jr. et al. | Oct 1991 | A |
5099833 | Michaels | Mar 1992 | A |
5613489 | Miller et al. | Mar 1997 | A |
5988160 | Foley et al. | Nov 1999 | A |
20100180891 | McKinnon et al. | Jul 2010 | A1 |
Number | Date | Country |
---|---|---|
293900 | Jul 1928 | GB |
Entry |
---|
Official Action for U.S. Appl. No. 12/688,295 mailed Mar. 20, 2013, 6 pages. |
Official Action for U.S. Appl. No. 12/688,295 mailed Apr. 11, 2013, 9 pages. |
Number | Date | Country | |
---|---|---|---|
20110277754 A1 | Nov 2011 | US |
Number | Date | Country | |
---|---|---|---|
61145318 | Jan 2009 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12688295 | Jan 2010 | US |
Child | 13188793 | US |